ROHTO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,962 JPY | +1.37% |
|
+3.98% | +4.19% |
| Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
Chart calendar Rohto Pharmaceutical Co.,Ltd.
ffee532352bbffdb1d9f95dc38ac9e.XahMgfZptu9tQmUok7Gea2KDhZ79LWfAkkWh0xbTSc8.G948xJc41LgcADIQ49bfL1q6y6mHGlWixQf7nie8cbo72yLZnj2b2TgDIA~5050cafadae412dc21412d615a376f6e
Upcoming events on Rohto Pharmaceutical Co.,Ltd.
Past events on Rohto Pharmaceutical Co.,Ltd.
| 2024-03-27 | Final dividend |
| 2024-02-08 | Q3 2023 Earnings Call |
| 2024-02-08 | Q3 2023 Earnings Release |
| 2023-11-09 | Q2 2023 Earnings Release |
| 2023-09-27 | Ex-dividend day for dividende intermédiaire |
| 2023-08-08 | Q1 2023 Earnings Release |
| 2023-05-11 | Q4 2023 Earnings Release |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-02-12 | Q3 2022 Earnings Release |
| 2022-12-28 | Split: 2 of 1 |
| 2022-11-09 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-08-08 | Q1 2022 Earnings Release |
| 2022-05-11 | FY 2022 Earnings Release |
| 2022-03-29 | Ex-dividend day for final dividend |
| 2022-02-09 | Q3 2022 Earnings Release |
| 2021-11-10 | Interim 2021 Earnings Release |
| 2021-09-28 | Ex-dividend day for dividende intermédiaire |
| 2021-08-09 | Q1 2021 Earnings Release |
| 2021-05-11 | FY 2021 Earnings Release |
Past dividends on Rohto Pharmaceutical Co.,Ltd.
| 2024-03-27 | Final Payment 15 JPY |
| 2023-09-27 | Interim Payment 12 JPY |
| 2023-03-29 | Final Payment 12 JPY |
| 2022-09-28 | Interim Payment 20 JPY |
| 2022-03-29 | Final Payment 21 JPY |
| 2021-09-28 | Interim Payment 15 JPY |
| 2021-03-29 | Final Payment 15 JPY |
| 2020-09-28 | Interim Payment 13 JPY |
| 2020-03-29 | Final Payment 13 JPY |
| 2019-09-26 | Interim Payment 13 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 183 582 183 190 0.21% | 188 327 186 527 0.97% | 181 287 182 453 -0.64% | 199 646 195 206 2.27% | 238 664 237 333 0.56% | 271 113 |
|
EBITDA Million JPY | Released Forecast Spread | 27 216 27 075 0.52% | 30 022 27 480 9.25% | 29 738 28 155 5.62% | 37 022 35 892 3.15% | 41 760 42 380 -1.46% | 49 785 |
|
EBIT Million JPY | Released Forecast Spread | 20 812 21 325 -2.41% | 23 085 21 952 5.16% | 22 990 21 925 4.86% | 29 349 28 364 3.47% | 33 959 34 150 -0.56% | 41 063 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 16 300 20 667 -21.13% | 21 730 21 578 0.71% | 23 006 21 863 5.23% | 27 953 28 922 -3.35% | 34 290 34 052 0.7% | 41 673 |
|
Net income Million JPY | Released Forecast Spread | 9 799 13 030 -24.8% | 15 410 13 686 12.6% | 16 743 14 148 18.34% | 21 018 19 979 5.2% | 26 377 24 677 6.89% | 31 036 |
|
EPS JPY | Released Forecast Spread | 43,0 56,5 -23.88% | 67,6 60,0 12.62% | 73,4 62,0 18.42% | 92,1 87,5 5.24% | 116 103 12.48% | 136 |
| Announcement Date | 10/05/19 | 12/05/20 | 12/05/21 | 12/05/22 | 12/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 90 428 87 953 2.81% | 97 899 97 636 0.27% | 83 004 83 714 -0.85% | 98 283 100 096 -1.81% | 91 019 88 148 3.26% | 53 003 48 280 9.78% | 55 624 51 227 8.58% | 108 627 150 800 -27.97% | 52 255 47 930 9.02% | 58 058 54 548 6.43% | 110 313 104 200 5.87% | 65 950 58 533 12.67% | 62 401 60 979 2.33% | 61 171 57 732 5.96% | 66 698 65 582 1.7% | 127 869 126 386 1.17% | 73 294 73 819 -0.71% | 71 304 | 145 100 | 67 450 | 73 250 | 140 100 | 80 700 | 75 100 | 154 400 |
|
EBIT Million JPY | Released Forecast Spread | 10 393 9 780 6.27% | 12 692 11 104 14.31% | 10 779 9 319 15.66% | 12 211 10 921 11.81% | 13 771 13 089 5.21% | 9 777 6 327 54.54% | 5 801 5 104 13.67% | 15 578 15 015 3.75% | 8 302 6 326 31.24% | 7 967 8 387 -5.01% | 16 269 15 400 5.64% | 12 329 9 393 31.25% | 5 361 5 600 -4.27% | 11 292 9 241 22.19% | 9 674 9 594 0.83% | 20 966 20 646 1.55% | 14 296 14 314 -0.13% | 5 653 | 19 700 | 11 950 | 11 200 | 23 800 | 16 250 | 7 600 | 23 700 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 10 478 | 11 252 11 717 -3.97% | 9 050 9 628 -6.01% | 13 956 11 410 22.31% | 13 840 11 200 23.57% | 9 709 6 300 54.11% | 4 404 4 300 2.42% | 9 655 6 600 46.29% | 8 155 6 800 19.93% | 17 810 13 400 32.91% | 11 717 10 100 16.01% | 4 763 3 500 36.09% | 12 242 9 651 26.84% | 10 302 9 749 5.67% | 22 544 21 600 4.37% | 14 026 15 028 -6.67% | |||||||||
|
Net income Million JPY | Released Forecast Spread | 7 305 5 959 22.6% | 8 105 6 598 22.85% | 6 178 6 846 -9.75% | 10 565 8 422 25.45% | 10 756 8 016 34.19% | 6 177 4 410 40.07% | 4 085 3 688 10.76% | 10 262 9 844 4.25% | 6 994 4 600 52.04% | 6 198 5 103 21.46% | 13 192 10 200 29.33% | 8 445 6 377 32.44% | 4 740 3 154 50.27% | 9 090 6 936 31.06% | 7 504 7 071 6.13% | 16 594 16 300 1.8% | 9 563 10 519 -9.09% | 5 038 | |||||||
|
EPS JPY | Released Forecast Spread | 32,0 24,6 30.01% | 27,1 25,1 7.72% | 47,2 40,9 15.28% | 27,1 20,7 30.86% | 17,9 14,9 20.25% | 30,7 18,4 66.54% | 27,2 22,8 19.14% | 57,8 | 37,0 24,2 53.14% | 39,9 27,6 44.28% | 32,9 30,4 8.06% | 72,7 | 41,9 | 21,2 | 38,1 | 34,6 | 53,0 | ||||||||
| Announcement Date | 13/11/19 | 12/05/20 | 12/11/20 | 12/05/21 | 11/11/21 | 10/02/22 | 12/05/22 | 12/05/22 | 09/08/22 | 10/11/22 | 10/11/22 | 13/02/23 | 12/05/23 | 09/08/23 | 10/11/23 | 10/11/23 | 09/02/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Rohto Pharmaceutical Co.,Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4527 Stock
- Calendar Rohto Pharmaceutical Co.,Ltd.
